IFP Advisors’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-81
| Closed | -$6 | – | 3398 |
|
|
2023
Q3 | $6 | Buy |
81
+80
| +8,000% | +$423 | ﹤0.01% | 3278 |
|
|
2023
Q2 | $6 | Hold |
1
| – | – | ﹤0.01% | 3432 |
|
|
2023
Q1 | $373 | Hold |
1
| – | – | ﹤0.01% | 3220 |
|
|
2022
Q4 | $2K | Sell |
1
-20
| -95% | -$2.88K | ﹤0.01% | 4251 |
|
|
2022
Q3 | $4K | Hold |
21
| – | – | ﹤0.01% | 4171 |
|
|
2022
Q2 | $4K | Buy |
21
+20
| +2,000% | +$11K | ﹤0.01% | 3933 |
|
|
2022
Q1 | $4K | Hold |
1
| – | – | ﹤0.01% | 3931 |
|
|
2021
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 2867 |
|
|
2021
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 2914 |
|
|
2021
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 2805 |
|
|
2021
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 2734 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3126 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3032 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2996 |
|
|
2020
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 2418 |
|
|
2019
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 2748 |
|
|
2019
Q3 | $2K | Buy |
+1
| New | +$3.29K | ﹤0.01% | 2746 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$2K | – | 3565 |
|
|
2018
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 3216 |
|
|
2018
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 3344 |
|
|
2018
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 3648 |
|
|
2018
Q1 | $4K | Hold |
1
| – | – | ﹤0.01% | 3305 |
|
|
2017
Q4 | $4K | Hold |
1
| – | – | ﹤0.01% | 3353 |
|
|
2017
Q3 | $6K | Hold |
1
| – | – | ﹤0.01% | 3337 |
|
|
2017
Q2 | $10K | Hold |
1
| – | – | ﹤0.01% | 3039 |
|
|
2017
Q1 | $14K | Hold |
1
| – | – | ﹤0.01% | 2740 |
|
|
2016
Q4 | $14K | Hold |
1
| – | – | ﹤0.01% | 2720 |
|
|
2016
Q3 | $18K | Hold |
1
| – | – | ﹤0.01% | 2483 |
|
|
2016
Q2 | $12K | Buy |
+1
| New | +$15.8K | ﹤0.01% | 2673 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$11K | – | 3551 |
|
|
2015
Q4 | $11K | Buy |
+1
| New | +$10.9K | ﹤0.01% | 2547 |
|
Other funds holding BIOL
IFP Advisors's BIOL Position: Q4 2023 in Review
IFP Advisors sold out of Biolase (BIOL) in Q4 2023, closing a stake of 81 shares — an estimated $6 sold.
IFP Advisors first reported a position in BIOL in Q4 2015 and held it in 29 quarters. The position peaked at $18K in Q3 2016. 16 funds tracked by Wall St. Rank hold BIOL as of Q4 2023.
- IFP Advisors reported no remaining Biolase position as of Q4 2023 after selling out during the quarter.
- IFP Advisors sold 81 Biolase shares in Q4 2023, an estimated $6.
- IFP Advisors first reported a position in Biolase in Q4 2015 and held it in 29 quarters.
- IFP Advisors's Biolase position peaked at $18K in Q3 2016.
- 16 funds tracked by Wall St. Rank held Biolase as of Q4 2023.
Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.